High detection rates of pancreatic cancer across stages by plasma assay of novel methylated DNA markers and CA 19-9

BACKGROUND & AIMS: We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case-control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. METHODS: Thirteen MDMs (GRIN2D, CD1D, ZNF781, FER1L4,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Majumder, Shounak, Taylor, William R., Foote, Patrick H., Berger, Calise K., Wu, Chung Wah, Mahoney, Douglas W., Bamlet, William R., Burger, Kelli N., Postier, Neil, de la Fuente, Jaime, Doering, Karen A., Lidgard, Graham P., Allawi, Hatim T., Petersen, Gloria M., Chari, Suresh T., Ahlquist, David A., Kisiel, John B.
Format: Artigo
Jezik:Inglês
Izdano: 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102343/
https://ncbi.nlm.nih.gov/pubmed/33593879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0235
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items